Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Vaccines
Data on HIV/AIDS vaccines discussed by researchers at Australian National University
July 2nd, 2008
Current study results from the report, 'Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy,' have been published. According to recent research from Canberra, Australia, "The type I IFNs exert a range of activities that include antiviral, antiproliferative, and immunomodulatory effects. To study this further, we have constructed recombinant vaccinia viruses expressing HIV or hemagglutinin (HA) Ags along with murine type I IFNs, IFN-alpha(4) (HA-VV-IFN-alpha(4)), IFN-beta (HA-VV-IFN-beta), or IFN-epsilon (HIV-VV-IFN-epsilon), a recently discovered member of this family." "Our aims were to characterize...
Source: Vaccine Weekly (2008-07-02)
|
